Some interesting molecules help distinguish age-related memory loss from Alzheimer’s disease and suggest promising new avenues for research.
A study on the effects of the FDA’s warnings about antidepressants’ increased risk of suicidality leads to different interpretations.
A chromatin-related gene may contribute not just to schizophrenia, but to obsessive-compulsive and other psychiatric disorders.
When menopausal women cannot or do not want to take estrogen to combat bothersome hot flashes and night sweats, antidepressants may serve as an effective alternative.
Glutamte may serve as a potential biomarker to predict pathophysiologies of specific psychiatric disorders in youth.
The workings of the amygdala explain some of the symptoms of posttraumatic stress disorder, but understanding others requires attention elsewhere in the brain.
While researchers are beginning to understand more about factors linking violence and mental illness, much more research needs to be done to identify individuals at risk.
Several genes that are implicated in alcoholism disorders have also been associated with cocaine addiction and with anxiety disorders, bipolar disorder, and schizophrenia.
Antidepressants have lowered levels of beta-amyloid in laboratory animals and some human volunteers, but future studies will have to determine whether the drugs can help prevent Alzheimer’s disease.
Read this week's Update
Sign Up for Psychiatric News Update newsletter